The oral cavity is at potential risk for SARS-CoV-2 infection, as the oral mucosa expresses ACE2 [1]. Similarly, interactions between SARS-CoV-2 and organs of the GI tract may occur via the ACE2, suggesting that the GIS is likely to be affected in COVID-19 [25]. The gene discussed is ACE2; the disease is COVID-19.